ECHOMARKETING Co.,Ltd. Logo

ECHOMARKETING Co.,Ltd.

Global agency accelerating sales with data-driven, full-funnel digital marketing.

230360 | KO

Overview

Corporate Details

ISIN(s):
KR7230360000
LEI:
Country:
South Korea
Address:
서울특별시 송파구 올림픽로35다길 42 한국루터회관 9,10,15층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ECHOMARKETING Co., Ltd. is a global digital marketing agency focused on accelerating client sales growth. The company designs and executes data-driven, full-funnel marketing strategies that span the entire customer journey. Its comprehensive service suite includes strategic planning, creative production optimized through A/B testing, in-house campaign management, advanced data analysis, and CRM. The firm operates with a unique "UNIT" system, assembling cross-functional teams of specialists from areas such as e-commerce, finance, media buying, and data science to address specific client objectives. With a global presence in over 50 countries, ECHOMARKETING provides solutions in performance marketing, programmatic advertising, and search marketing management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Notice of Dividend Amount
수시공시의무관련사항(공정공시) (2025년(제23기) 3분기배당 계획)
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-11 00:00
Transaction in Own Shares
자기주식취득결과보고서
Korean 30.4 KB
2025-08-11 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.6 KB
2025-08-11 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.5 KB
2025-08-11 00:00
Share Issue/Capital Change
주식소각결정
Korean 9.0 KB
2025-07-15 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
Korean 32.6 KB
2025-07-15 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식취득결정)
Korean 35.4 KB
2025-05-16 00:00
Board/Management Information
대표이사변경
Korean 9.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.2 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.1 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 24.5 KB

Automate Your Workflow. Get a real-time feed of all ECHOMARKETING Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ECHOMARKETING Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ECHOMARKETING Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.